Differential effects of antipsychotic agents on the risk of development of type 2 diabetes mellitus in patients with mood disorders
- 1 April 2003
- journal article
- research article
- Published by Elsevier BV in Clinical Therapeutics
- Vol. 25 (4), 1150-1171
- https://doi.org/10.1016/s0149-2918(03)80073-5
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Resolution of Hyperglycemia on Risperidone DiscontinuationPublished by Physicians Postgraduate Press, Inc ,2002
- Association of Diabetes Mellitus With Use of Atypical Neuroleptics in the Treatment of SchizophreniaAmerican Journal of Psychiatry, 2002
- Clozapine-Induced Diabetic KetoacidosisAustralian & New Zealand Journal of Psychiatry, 1999
- Diabetic ketoacidosis and clozapineHeart, 1998
- Weight Gain in Adolescents Treated with Risperidone and Conventional Antipsychotics Over Six MonthsJournal of Child and Adolescent Psychopharmacology, 1998
- Changing antipsychotic medication: guidelines on the transition to treatment with RisperidoneClinical Therapeutics, 1996
- Ketoacidosis as a side‐effect of clozapine: a case reportActa Psychiatrica Scandinavica, 1996
- White matter signal abnormalities in normal individuals: correlation with carotid ultrasonography, cerebral blood flow measurements, and cerebrovascular risk factors.Stroke, 1988
- Affective Disorders, Diabetes Mellitus and LithiumAustralian & New Zealand Journal of Psychiatry, 1981
- Studies on the Mechanism of Pentobarbital-Induced Glucose IntoleranceHormone and Metabolic Research, 1971